Turn Biotechnologies First to Deliver mRNA into the Dermis Using Proprietary LNPs, With No Distribution to Other Organs
- Written by PR Newswire
- Company's eTurna™ delivery platform ensures unprecedented precision, safety
- In-vivo biodistribution of mRNA into dermal cells, tissues shows high transfection efficiency, gene expression
- Data presented at ASDS Annual Meeting
MOUNTAIN VIEW, Calif., Nov. 7, 2023 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation developer of novel...














